Targeting LRRK2 mutations in Parkinson's disease

被引：1
|
作者：
Lesniak, Robert K. [1 ,2 ]
Nichols, Robert Jeremy [2 ]
Smith, Mark [1 ]
Montine, Thomas J. [2 ]
机构：
[1] Stanford Univ, Sarafan ChEM H, Med Chem Knowledge Ctr, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Pathol, 300 Pasteur Dr, Stanford, CA 94305 USA
来源：
FUTURE MEDICINAL CHEMISTRY | 2022年 / 14卷 / 16期
关键词：
computational chemistry and molecular modeling; drug design; drug discovery; inflammation therapeutics; neurological therapeutics; pharmacokinetics; pharmacodynamics; rare diseases; IDENTIFICATION; METAANALYSIS; DISCOVERY; DESIGN;
D O I：
10.4155/fmc-2022-0102
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：1167 / 1170
页数：4
相关论文
共 50 条
  • [1] Targeting LRRK2 in Parkinson's disease
    Xiao, Bin
    Tan, Eng-King
    CELL REPORTS MEDICINE, 2022, 3 (10)
  • [2] LRRK2 mutations in Parkinson disease
    Farrer, M
    Stone, J
    Mata, IF
    Lincoln, S
    Kachergus, J
    Hulihan, M
    Strain, KJ
    Maraganore, DM
    NEUROLOGY, 2005, 65 (05) : 738 - 740
  • [3] Identification of LRRK2 mutations in Parkinson's disease
    Lewthwaite, A. J.
    Nicholl, D. J.
    Morrison, K. E.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (12): : 1397 - 1397
  • [4] Mutations in LRRK2 as a cause of Parkinson's disease
    Giasson, Benoit I.
    Van Deerlin, Vivianna M.
    NEUROSIGNALS, 2008, 16 (01) : 99 - 105
  • [5] The Discovery of LRRK2 Mutations as a Cause of Parkinson's Disease
    Singleton, Andrew B.
    Gasser, Thomas
    MOVEMENT DISORDERS, 2020, 35 (04) : 551 - 554
  • [6] Genetics in Parkinson's disease -: the role of LRRK2 mutations
    Toft, M.
    ACTA NEUROLOGICA SCANDINAVICA, 2008, 117 (01): : 70 - 70
  • [7] A study of LRRK2 mutations and Parkinson's disease in Brazil
    Pimentel, M. M. G.
    Moura, K. C. V.
    Abdalla, C. B.
    Pereira, J. S.
    Rosso, A. L. Z.
    Nicaretta, D. H.
    Campos, M., Jr.
    Almeida, R. M.
    Santos, J. M.
    Bastos, I. C. G.
    Mendes, M. F. X.
    Maultasch, H.
    Costa, F. H. R.
    Werneck, A. L. S.
    Santos-Reboucas, C. B.
    MOVEMENT DISORDERS, 2008, 23 (01) : S41 - S41
  • [8] LRRK2 mutations and Parkinson's disease in the Uruguayan population
    Raggio, V. E.
    Dieguez, E.
    Lescano, A.
    Aguiar, B.
    Aljanati, R.
    Martinovic, M.
    Amorin, I.
    Gonzalez, N.
    Ojeda, A. J.
    Pomar, V.
    Nogueira, G.
    Aguerre, L.
    Montado, G.
    Etchandi, G.
    Segredo, E.
    Soler, A. M.
    Yearout, D.
    Huston, H.
    Buzo, R.
    Zabetian, C. P.
    Mata, I. F.
    MOVEMENT DISORDERS, 2013, 28 : S399 - S399
  • [9] Prevalence of LRRK2 mutations in Australians with Parkinson's disease
    Huang, Y.
    Halliday, G. M.
    Vandebona, H.
    Mellick, G. D.
    Mastaglia, F. L.
    Stevens, J.
    Kwok, J.
    Garlepp, M.
    Silburn, P. A.
    Horne, M. K.
    Kotschet, K. E.
    Venn, A.
    Rowe, D. B.
    Rubio, J. P.
    Sue, C. M.
    MOVEMENT DISORDERS, 2007, 22 : S83 - S83
  • [10] LRRK2 mutations in Basque patients with Parkinson's disease
    Zarranz, Juan J.
    Gomez-Esteban, Juan Carlos
    LANCET NEUROLOGY, 2008, 7 (10): : 866 - 867
12345